OR WAIT null SECS
September 26, 2017
Additional reactor capacity and a wastewater processing plant increase API manufacturing capacity at the Cambrex site in Kalskoga, Sweden.
ADC Bio announces plans to expand into clinical and commercial drug manufacturing for ADCs.
September 25, 2017
BASF will build a new specialty amines plant at its existing wholly owned site in Nanjing Chemical Industry Park in China.
September 21, 2017
Ajinomoto Althea opens manufacturing suites in new high potency and antibody drug conjugate commercial facility.
September 02, 2017
Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.
Drug repurposing, repositioning, and rescue can be faster, cheaper, and target more diseases than traditional drug discovery approaches.
September 01, 2017
Innovative new technologies released over the past several months seek to enhance bio/pharmaceutical development and manufacturing.
August 14, 2017
The private investment firm’s $110-million acquisition boosts its API and finished dosage form value chain.
August 10, 2017
Cambrex is investing $24 Million in new, highly potent API manufacturing capacity at its Charles City, Iowa site.
August 07, 2017
Featuring software, parallel automated reactors, and other tools designed to facilitate design of experiments, development of the design space, and better process understanding and control, the Hyderabad facility came online on July 20